Search Results - "Berendzen, Ashley"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer by Thomas, Brian J., Guldenpfennig, Caitlyn, Guan, Yue, Winkler, Calvin, Beecher, Margaret, Beedy, Michaela, Berendzen, Ashley F., Ma, Lixin, Daniels, Mark A., Burke, Donald H., Porciani, David

    Published in Molecular therapy. Nucleic acids (12-12-2023)
    “…A significant fraction of non-small cell lung cancer (NSCLC) cases are due to oncogenic mutations in the tyrosine kinase domain of the epidermal growth factor…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Abstract 4412: Assessing protease inhibition enhanced delivery of prostate tumor targeted peptide receptor based radiotherapy by Rold, Tammy L., Bernskoetter, Nicole E., Berendzen, Ashley F., Hoffman, Timothy J.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Purpose: Peptide receptor targeted therapy for treatment of castration resistant prostate cancer (CRPC) has been explored by several groups including our own…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Targeting the BB2 receptor in prostate cancer using a Pb-203 labeled peptide by Okoye, Nkemakonam, Rold, Tammy, Berendzen, Ashley, Zhang, Xiuli, White, Reneise, Schultz, Michael, Li, Mengshi, Dresser, Thomas, Jurisson, Silvia, Quinn, Thomas, Hoffman, Timothy

    Published in The Journal of nuclear medicine (1978) (01-05-2017)
    “…Objectives: The objective of this study is to prepare and assess the efficacy of in vivo tumor targeting of 203Pb-RM2, a BB2r antagonist, for targeting BB2r…”
    Get full text
    Journal Article
  8. 8

    Abstract 4927: 68Ga/177Lu-Peptide antagonist targeting of breast cancer: A xenograft evaluation by Rold, Tammy L., Berendzen, Ashley F., Bernskoetter, Nicole E., Rushin, Jillian C., Ma, Lixin, Hoffman, Timothy J.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Introduction: Recent progress in developing BB2r (bombesin receptor subtype 2) antagonist vectors with long term cellular retention has captured significant…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Synthesis and evaluation of a 99m Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors by Radford, Lauren, Gallazzi, Fabio, Watkinson, Lisa, Carmack, Terry, Berendzen, Ashley, Lewis, Michael R, Jurisson, Silvia S, Papagiannopoulou, Dionysia, Hennkens, Heather M

    Published in Nuclear medicine and biology (01-04-2017)
    “…A somatostatin receptor (SSTR)-targeting antagonist peptide (sst -ANT) was radiolabeled with Tc tricarbonyl via a tridentate [N,S,N]-type ligand (L) to develop…”
    Get full text
    Journal Article
  13. 13